About this trial
Evaluate the protein expression of lactate dehydrogenase enzyme (LDHA) and MCT-1/-4 transporters, involved in lactate synthesis and transport, in prostate carcinoma tissues from severely overweight/obese (BMI \> 27.5) and non-severely overweight/normoweight (BMI \< 27.5) patients affected by prostate carcinoma.
ii. Characterize the immune infiltrate in the prostate carcinoma of the aforementioned patients.
iii. Assess the association between intra-tumoral lactate accumulation (using LDHA and MCT-4 protein expression levels as readouts) and alterations in the tumor immune microenvironment and/or deregulation of relevant oncogenic pathways.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
affected by prostate cancer
Disqualifiers
None
Trial population
patients affected bt prostate cancer both obese or not obese
Trial design
Case-control
Retrospective
Treatments tested in this trial
observational study
Other interventionobservational study
Treatment groups
Trial outcomes
Primary outcomes
Assess the protein expression of LDHA enzyme and MCT-1/-4 transporters in prostate carcinoma
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Lead sponsor
National Research Council
Collaborator